Literature DB >> 32034658

Germline Mutations in Familial Papillary Thyroid Cancer.

Marta Sarquis1, Debora C Moraes2, Luciana Bastos-Rodrigues3, Pedro G Azevedo2, Adauto V Ramos4, Fabiana Versiani Reis2, Paula V Dande2, Isabela Paim2, Eitan Friedman5,6, Luiz De Marco7.   

Abstract

Thyroid cancer, predominantly of papillary histology (PTC), is a common cancer mostly diagnosed sporadically. Hereditary PTC is encountered in ~ 5% of cases and may present at an earlier age, with greater risks of metastasis and recurrence, compared with sporadic cases. The molecular basis of hereditary PTC is unknown in most cases. In this study, the genetic basis of hereditary PTC in three Brazilian families was investigated. Whole exome sequencing (WES) was carried out for probands in each family, and validated, pathogenic/likely pathogenic sequence variants (P/LPSVs) were genotyped in additional family members to establish their putative pathogenic role. Overall, seven P/LPSVs in seven novel genes were detected: p.D283N*ANXA3, p.Y157S*NTN4, p.G172W*SERPINA1, p.G188S*FKBP10, p.R937C*PLEKHG5, p.L32Q*P2RX5, and p.Q76*SAPCD1. These results indicate that these novel genes are seemingly associated with hereditary PTC, but extension and validation in other PTC families are required.

Entities:  

Keywords:  Candidate genes; Hereditary papillary thyroid carcinoma; Inherited predisposition; Whole exome sequencing

Year:  2020        PMID: 32034658     DOI: 10.1007/s12022-020-09607-4

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  42 in total

1.  HABP2 Mutation and Nonmedullary Thyroid Cancer.

Authors:  Jerneja Tomsic; Huiling He; Albert de la Chapelle
Journal:  N Engl J Med       Date:  2015-11-19       Impact factor: 91.245

Review 2.  Genetic modifiers and oligogenic inheritance.

Authors:  Maria Kousi; Nicholas Katsanis
Journal:  Cold Spring Harb Perspect Med       Date:  2015-06-01       Impact factor: 6.915

3.  Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies.

Authors:  Chengliang Dong; Peng Wei; Xueqiu Jian; Richard Gibbs; Eric Boerwinkle; Kai Wang; Xiaoming Liu
Journal:  Hum Mol Genet       Date:  2014-12-30       Impact factor: 6.150

4.  Identification of a novel germline FOXE1 variant in patients with familial non-medullary thyroid carcinoma (FNMTC).

Authors:  Joana S Pereira; Joana Gomes da Silva; Rute Alexandra Tomaz; António Evaristo Pinto; Maria João Bugalho; Valeriano Leite; Branca Maria Cavaco
Journal:  Endocrine       Date:  2014-11-09       Impact factor: 3.633

5.  Decreased annexin A3 expression correlates with tumor progression in papillary thyroid cancer.

Authors:  Eun-Jung Jung; Hyeong-Gon Moon; Soon-Tae Park; Bok-Im Cho; Sun-Min Lee; Chi-Young Jeong; Young-Tae Ju; Sang-Ho Jeong; Young-Joon Lee; Sang-Kyung Choi; Woo-Song Ha; Jong Sil Lee; Kee Ryeon Kang; Soon-Chan Hong
Journal:  Proteomics Clin Appl       Date:  2010-02-26       Impact factor: 3.494

Review 6.  Familial non-medullary thyroid cancer: unraveling the genetic maze.

Authors:  Samantha Peiling Yang; Joanne Ngeow
Journal:  Endocr Relat Cancer       Date:  2016-11-02       Impact factor: 5.678

7.  The HABP2 G534E variant is an unlikely cause of familial non-medullary thyroid cancer.

Authors:  Ruta Sahasrabudhe; Jacob Stultz; John Williamson; Paul Lott; Ana Estrada; Mabel Bohorquez; Claire Palles; Guadalupe Polanco-Echeverry; Emma Jaeger; Lynn Martin; Maria Magdalena Echeverry; Ian Tomlinson; Luis G Carvajal-Carmona
Journal:  J Clin Endocrinol Metab       Date:  2015-12-21       Impact factor: 5.958

8.  Identification of SERPINA1 as single marker for papillary thyroid carcinoma through microarray meta analysis and quantification of its discriminatory power in independent validation.

Authors:  Klemens Vierlinger; Markus H Mansfeld; Oskar Koperek; Christa Nöhammer; Klaus Kaserer; Friedrich Leisch
Journal:  BMC Med Genomics       Date:  2011-04-06       Impact factor: 3.063

9.  Identifying and targeting determinants of melanoma cellular invasion.

Authors:  Aparna Jayachandran; Prashanth Prithviraj; Pu-Han Lo; Marzena Walkiewicz; Matthew Anaka; Briannyn L Woods; BeeShin Tan; Andreas Behren; Jonathan Cebon; Sonja J McKeown
Journal:  Oncotarget       Date:  2016-07-05

10.  Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer.

Authors:  Ruikai Du; Bingjie Liu; Lei Zhou; Dong Wang; Xueyan He; Xiaojun Xu; Lixing Zhang; Chaoshi Niu; Suling Liu
Journal:  Cell Death Dis       Date:  2018-01-26       Impact factor: 8.469

View more
  7 in total

Review 1.  Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes.

Authors:  Vania Nosé; Anthony Gill; José Manuel Cameselle Teijeiro; Aurel Perren; Lori Erickson
Journal:  Endocr Pathol       Date:  2022-03-13       Impact factor: 3.943

Review 2.  Inherited Follicular Epithelial-Derived Thyroid Carcinomas: From Molecular Biology to Histological Correlates.

Authors:  José Manuel Cameselle-Teijeiro; Ozgur Mete; Sylvia L Asa; Virginia LiVolsi
Journal:  Endocr Pathol       Date:  2021-01-25       Impact factor: 3.943

Review 3.  Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys.

Authors:  María Sánchez-Ares; Soledad Cameselle-García; Ihab Abdulkader-Nallib; Gemma Rodríguez-Carnero; Carolina Beiras-Sarasquete; José Antonio Puñal-Rodríguez; José Manuel Cameselle-Teijeiro
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-28       Impact factor: 5.555

Review 4.  Genetic susceptibility to hereditary non-medullary thyroid cancer.

Authors:  Tina Kamani; Parsa Charkhchi; Afshan Zahedi; Mohammad R Akbari
Journal:  Hered Cancer Clin Pract       Date:  2022-03-07       Impact factor: 2.857

Review 5.  Genetic Mutations and Variants in the Susceptibility of Familial Non-Medullary Thyroid Cancer.

Authors:  Fabíola Yukiko Miasaki; Cesar Seigi Fuziwara; Gisah Amaral de Carvalho; Edna Teruko Kimura
Journal:  Genes (Basel)       Date:  2020-11-18       Impact factor: 4.096

6.  Identification of NID1 as a novel candidate susceptibility gene for familial non-medullary thyroid carcinoma using whole-exome sequencing.

Authors:  Luis Eduardo Barbalho de Mello; Thaise Nayane Ribeiro Carneiro; Aline Neves Araujo; Camila Xavier Alves; Pedro Alexandre Favoretto Galante; Vanessa Candiotti Buzatto; Maria das Graças de Almeida; Karina Marques Vermeulen-Serpa; Sancha Helena de Lima Vale; Fernando José de Pinto Paiva; José Brandão-Neto; Janete Maria Cerutti
Journal:  Endocr Connect       Date:  2022-01-31       Impact factor: 3.335

7.  Down-Regulation of an Autophagy-Related Gene SERPINA1 as a Superior Prognosis Biomarker Associates with Relapse and Distant Metastasis in Colon Adenocarcinoma.

Authors:  Chen Fu; Zhaojin Yu; Ying He; Jian Ding; Minjie Wei
Journal:  Onco Targets Ther       Date:  2021-06-22       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.